Baxter Hlthcare patents expiration

1. Nexterone patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6869939 BAXTER HLTHCARE Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
May, 2022

(1 year, 4 months ago)

US7635773 BAXTER HLTHCARE Sulfoalkyl ether cyclodextrin compositions
Mar, 2029

(5 years from now)

Drugs and Companies using AMIODARONE HYDROCHLORIDE ingredient

Market Authorisation Date: 24 December, 2008

Treatment: NA


More Information on Dosage

NEXTERONE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic